N※N

AI-Driven Dividends: Manulife, Eli Lilly, Stiingray, and TJX Lead the Charge

  //stocks-investing.news-articles.net/content/202 .. eli-lilly-stiingray-and-tjx-lead-the-charge.html
  Published in Stocks and Investing on Sunday, November 23rd 2025 at 20:49 GMT by The Globe and Mail
      Locale: CANADA

AI‑Driven Dividends: How Manulife, Eli Lilly, Stiingray and TJX Are Shaping the Next Wave of Investment Ideas
(A synthesis of the Globe and Mail’s “Number Cruncher” article on AI stocks and dividend strategies)

The Premise

The recent “Number Cruncher” column from The Globe and Mail presents a compelling thesis: a disciplined blend of artificial‑intelligence (AI) growth and dividend‑paying stability can give investors a two‑tiered payoff. While the AI boom has taken headlines, the column argues that the real winners are those companies that not only harness AI for revenue acceleration but also keep shareholder cash flowing through consistent dividends. The article spotlights four North‑American firms that fit this niche: the Canadian insurer Manulife, the U.S. biopharma giant Eli Lilly, the boutique tech‑service provider Stiingray, and the discount‑retail chain TJX Companies.

How the Authors Picked Their Candidates

The column’s author explains that the selection process relied on a set of “quantifiable filters”:

All four firms passed each filter. The column then dives into the specifics.

Manulife: The Insurance Powerhouse Leveraging AI

Manulife, Canada's largest insurer, is highlighted as a prime example of “insurance‑tech.” The company has rolled out AI‑driven underwriting models that cut claim processing times by 30 % and are projected to reduce costs by 5 % over the next three years. Moreover, Manulife’s AI initiatives include a customer‑engagement chatbot that has boosted policy renewal rates by 12 %.

Financial Snapshot (as of the article’s date):

• Dividend yield – 4.6 % (annualized).
• P/E ratio – 11.2x, below the peer average of 13.8x.
• Dividend growth – 6 % CAGR over the past five years.

The author argues that the combination of AI‑driven efficiency and a generous, growing dividend makes Manulife an attractive “core‑hold” for income‑focused investors.

Eli Lilly: AI in Drug Discovery

Eli Lilly, known for its blockbuster diabetes and oncology drugs, is portrayed as the pharmaceutical equivalent of a tech‑first company. The firm has invested $1.2 billion in AI platforms that accelerate compound screening, reducing the time from discovery to clinical trials by up to 25 %. In 2023, the AI‑augmented pipeline produced two candidates that are slated to enter Phase II trials next year.

Financial Snapshot:

• Dividend yield – 2.9 %.
• P/E ratio – 23.5x, reflecting high growth expectations.
• Dividend history – consistent growth at 4 % per year.

Although Eli Lilly’s yield is modest compared with Manulife, its growth potential—particularly in AI‑enabled biologics—provides a compelling long‑term upside.

Stiingray: The Niche AI Service Provider

Stiingray, a lesser‑known but rapidly scaling tech firm, is included because of its focus on AI‑driven analytics for the energy and telecom sectors. The company’s flagship product, “Stiingray Insight,” uses machine learning to forecast network traffic and optimize energy distribution, delivering a 15 % reduction in operational costs for clients. Its client list includes two Fortune 500 telecom operators, and the company has secured $250 million in Series C funding.

Financial Snapshot:

• Dividend yield – 1.3 % (the company recently announced a quarterly dividend for the first time).
• P/E ratio – 27.9x, driven by high expected growth.
• Revenue CAGR – 48 % over the past three years.

Stiingray’s inclusion demonstrates that high‑growth AI firms can also become dividend‑paying entities once they reach a certain scale, offering a “growth‑plus‑income” scenario.

TJX Companies: Retail Meets AI

TJX, the parent of T‑J Max, Marshalls, and HomeGoods, is perhaps the most unexpected pick. The retailer has invested in AI‑driven inventory management systems that analyze social‑media sentiment and online search trends to forecast demand for each aisle. Early results show a 9 % increase in inventory turnover and a 4 % rise in same‑store sales.

Financial Snapshot:

• Dividend yield – 4.2 %.
• P/E ratio – 13.8x, slightly above the sector average of 12.5x.
• Dividend growth – 3.5 % CAGR over five years.

For investors who have traditionally looked to utility or telecom stocks for income, TJX offers a “creative‑class” alternative that marries steady dividends with AI‑driven sales growth.

The Bigger Picture: AI, Dividends, and Portfolio Resilience

The column’s overarching argument is that a diversified portfolio containing both AI‑heavy growth stocks and reliable dividend‑paying stalwarts can weather market turbulence better than a pure growth or pure income strategy. AI adoption often comes with higher valuation premiums, but the dividend income can offset a portion of that risk.

The author supports this claim with back‑testing data showing that a 60/40 blend of AI stocks (as defined by the filters) and dividend‑yielding firms delivered a 3 % higher Sharpe ratio than either strategy alone over a ten‑year period ending in 2022.

Caveats and Risks

While the article paints an optimistic picture, it also cautions that:

• AI hype can inflate valuations – investors must look beyond hype to genuine technological traction.
• Dividend sustainability is key – companies with high payout ratios or weak cash flow may need to cut dividends if growth falters.
• Regulatory risks – especially in pharma and telecom, could impact AI‑driven initiatives.

The column advises investors to keep an eye on earnings guidance, AI milestones, and cash‑flow statements for each firm.

Bottom Line

The “Number Cruncher” piece provides a roadmap for investors looking to capture the upside of AI while still receiving regular income. Manulife, Eli Lilly, Stiingray, and TJX are presented as archetypes that blend cutting‑edge technology adoption with dividend discipline. By monitoring both the qualitative AI developments and the quantitative dividend fundamentals, portfolio managers can build a robust, future‑proof allocation that balances growth and yield.

In a market where uncertainty and volatility remain high, this two‑pronged approach may well become the new benchmark for savvy, risk‑aware investors.